Adiponectin, a key adipokine in obesity related liver diseases

doi:10.3748/wjg.v17.i23.2801

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4535)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

530

HTML

3752

Figures (1-3)

253

Sum=4535

Jun 21, 2011 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 21, 2011; 17(23): 2801-2811
Published online Jun 21, 2011. doi: 10.3748/wjg.v17.i23.2801

Full Size Figure Download Figure

Figure 2 Epidemiology of non-alcoholic fatty liver disease. Current estimates of the prevalence of fatty liver, non-alcoholic steatohepatitis (NASH) and obesity-related liver cirrhosis in the general population and in obesity defined as body mass index (BMI) above 30 kg/m².

Citation: Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol 2011; 17(23): 2801-2811
URL: https://www.wjgnet.com/1007-9327/full/v17/i23/2801.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i23.2801